Hematology - European Medical Journal

Continue

Hematology

Articles
Hematology CP
22 Mins
28th April 2022

Social Impact and Quality of Life of Patients with β-Thalassaemia: A Systematic Review

Beta Thalassaemia forces patients to undergo frequent blood transfusions, which has a significant social impact on the quality of life…
4th April 2022

Infographic: Acute Myeloid Leukaemia (AML)

Acute Myeloid Leukaemia is rare cancer of the blood cells. This infographic provides an overview of this pathology, outlining epidemiology, symptoms, treatment options, and prognosis.
Hematology CP
5 Mins
28th March 2022

IMRT/IGRT Helical Tomotherapy: A Successful Treatment of Lung Parenchyma Compression Due to Extramedullary Haematopoiesis in β-Thalassaemia - A Case Report

Thalassaemia is an autosomal recessive haematological disorder that is characterised by defective synthesis of the globin moiety in…
16 Mins
22nd March 2022

Targeting the Immune System and Beyond: The Potential for Safe and Durable Responses in Higher-Risk Myelodysplastic Syndromes with Immuno-Myeloid Therapy

The hypomethylating agents (HMA), azacitidine and decitabine, are currently regarded as the standard of care for patients with…
21 Mins
18th March 2022

The Future of Gene Therapy for Haemophilia A and B: Innovative Treatment Management Strategies, Perspectives, and Updated Trial Results

Monogenic diseases such as haemophilia A and B are inherited conditions arising from mutations in a single gene. One defective gene leads…
15 Mins
21st February 2022

The Search for Sustained Durability in Higher-Risk Myelodysplastic Syndrome: New Treatment Pathways in Sight

Higher-risk MDS is a collective term based on the Revised International Prognostic Scoring System (IPSS-R) that encompasses…
6 Mins
3rd February 2022

Digital Necrosis as Initial Manifestation of Multiple Myeloma: An Unusual Case Report

Multiple myeloma (MM) is a B cell malignancy characterised by abnormal proliferation of plasma cells that expand in the bone marrow and produce a monoclonal Ig, also known as M-protein.
19 Mins
31st January 2022

Updates on Isatuximab in Relapsed/Refractory and Newly Diagnosed Multiple Myeloma

In the past decade, therapies that are more effective and less toxic have transformed the treatment landscape for patients with MM…